SEC Filings for CollPlant Biotechnologies Ltd. (CLGN)

$ 10.30   0.48 (+4.89%) Volume: 3.69k 10:56 AM EDT May 29, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934512/19/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341111/29/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19342111/22/2019
SC 13D/A[Amend] General statement of acquisition of beneficial ownership511/05/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934310/31/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19343709/26/2019
SC 13GStatement of acquisition of beneficial ownership by individuals1409/18/2019
SC 13GStatement of acquisition of beneficial ownership by individuals1409/18/2019
SC 13GStatement of acquisition of beneficial ownership by individuals509/16/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19342009/16/2019
DNotice of Exempt Offering of Securities109/10/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19342809/09/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934609/03/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934308/30/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934308/23/2019
123456789